Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Placebo - 2 Placebo DMTS Patches

Phase 2

TTeikoku Pharma USA, Inc.

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q2 2027

Phase 2Recruiting

Agitation

NCT06052254

Clinical

Trials by Indication[1]

Agitation1 trial

A Double-Blind, Placebo-Controlled Evaluation of the Dexmedetomidine Transdermal Systems for Agitation Associated With Dementia of the Alzheimer's Type

Recruiting·TTeikoku Pharma USA, Inc.·Phase 2·NCT06052254·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Placebo - 2 Placebo DMTS Patches. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Placebo - 2 Placebo DMTS Patches. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Teikoku Pharma USA, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: TTeikoku Pharma USA, Inc.

Related News